US 10722504
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
granted A61KA61K31/4465A61P
Quick answer
US patent 10722504 (4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jul 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4465, A61P, A61P11/06, A61P13/00